Descovy (emtricitabine / tenofovir alafenamide) is a prescription antiretroviral pill used to treat and prevent human immunodeficiency virus (HIV) infection. It's FDA approved for use with other HIV medications to treat HIV in adults and children. It's also approved for pre-exposure prophylaxis (PrEP) to help reduce the risk of getting HIV in adults and teens. You take it once a day by mouth, with or without food. Some common side effects include nausea and diarrhea.
Descovy (emtricitabine / tenofovir alafenamide) is a combination of two HIV antiretroviral medications: emtricitabine and tenofovir alafenamide.
Both medications are nucleoside reverse transcriptase inhibitors (NRTIs). They work by blocking an enzyme (protein) called reverse transcriptase, which HIV uses to make copies of itself. By stopping this process, Descovy (emtricitabine / tenofovir alafenamide) helps prevent the virus from spreading in the body and reduces the risk of infection when used for PrEP.
The following side effects may get better over time as your body gets used to the medication. Let your healthcare provider know immediately if you continue to experience these symptoms or if they worsen over time.
Note: Side effects were reported by people who took Descovy (emtricitabine / tenofovir alafenamide) alone for PrEP.
Contact your healthcare provider immediately if you experience any of the following.
Side effects that you should report to your care team as soon as possible:
Side effects that usually do not require medical attention (report to your care team if they continue or are bothersome):
More tips for HIV PrEP:
Yes, Descovy can be used as PrEP, also known as pre-exposure prophylaxis (prevention). In fact, it's one of the preferred PrEP options for people at risk of getting HIV through sex. But it's not recommended for females at risk through vaginal sex or people who share needles because it’s unclear how well it works in those situations. If you're thinking about taking PrEP, talk to a healthcare professional to find out which option is best for you.
If you're taking Descovy for PrEP, you need to take it every day for at least 7 days to get full protection against HIV according to the CDC. Taking it for just 3 days might not give you enough protection. Talk to your prescriber if you've been exposed to HIV.
Descovy is made up of two medications, and it takes about 2 days for both to fully leave your body. This estimate is based on the half-lives of emtricitabine and tenofovir alafenamide, which measure how long it takes for half of the medication to clear your system. But this timing can vary depending on things like your kidney health, age, or other health conditions.
In studies, people taking Descovy alone for PrEP didn't report weight gain as a side effect. But you might gain weight if you're taking it with other HIV medications to treat HIV. For example, research shows that people who took tenofovir alafenamide (one of the medications in Descovy) with an integrase inhibitor like Tivicay (dolutegravir) were more likely to gain weight compared to other HIV regimens. Keep in mind, this combination is one of the preferred treatments for people starting HIV therapy for the first time.
How long Descovy side effects last depends on the type of side effect and can vary from person to person. Common side effects like diarrhea and nausea often go away on their own. Others, like changes in kidney or liver health, might last longer and could continue even after stopping the medication. Talk to your prescriber about what to expect and how to manage any side effects.
Descovy starts working quickly, but how long it takes depends on why you’re taking it. For PrEP (HIV prevention), you need to take it daily for at least 7 days to reach full protection. If you’re taking it as part of HIV treatment (along with other HIV medications), it begins working right away to lower the amount of virus in your body, and many people see results within half a year.
Descovy for PrEP is approved to help prevent HIV in cisgender men, transgender women, and teens assigned male at birth who weigh at least 77 lbs. But the medication isn't for people at risk of HIV through vaginal sex, such as cisgender women, because it hasn’t been studied enough in that group. Always talk to a healthcare professional to find the best choice for you.
Descovy and Truvada are both daily pills used for PrEP (HIV prevention) and HIV treatment, but they have different forms of tenofovir. Descovy contains tenofovir alafenamide (TAF), which might be easier on the bones and kidneys, compared to tenofovir disoproxil fumarate (TDF) in Truvada. But Truvada is approved for a broader group of people, including adults and teens at risk of HIV through vaginal or anal sex, while Descovy is only approved for cisgender men, transgender women, and teens assigned male at birth, and not for people at risk through vaginal sex. Ask your prescriber if you have questions comparing the two medications.
Descovy (emtricitabine / tenofovir alafenamide) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
Before you start Descovy (emtricitabine / tenofovir alafenamide), your prescriber will test you for hepatitis B virus (HBV). If you already have hepatitis B, stopping Descovy (emtricitabine / tenofovir alafenamide) could suddenly make your liver condition worse (called an HBV flare-up). Don't stop taking the medication without talking with your prescriber first. Make sure to get your refills on time so you don't miss any doses. If you do need to stop taking the medication, your prescriber might continue to check your liver with blood tests for several months to watch for signs of an HBV flare-up.
Descovy (emtricitabine / tenofovir alafenamide) might not always fully prevent HIV infection, so it’s important to use other ways to protect yourself too. This includes practicing safer sex (like using condoms), knowing your partner’s HIV status, and getting tested at least every 3 months for HIV and other STIs. Taking Descovy (emtricitabine / tenofovir alafenamide) on time every day helps lower your chance of getting HIV.
Before starting Descovy (emtricitabine / tenofovir alafenamide), your prescriber might ask you about any recent situations where you could have been exposed to HIV — like unprotected sex or a recent STI. You'll also need to take an HIV test. Let your prescriber know if you have symptoms of HIV, such as fever, feeling tired, muscle pain, and skin rash, either before or during treatment.
Taking Descovy (emtricitabine / tenofovir alafenamide) can cause changes to your immune system known as immune reconstitution syndrome. This can happen when your immune system becomes more active after starting treatment and begins to fight infections it was too weak to handle before. You might notice signs of infections like tuberculosis (TB) or cytomegalovirus (CMV). In rare cases, your immune system might become so strong that it starts attacking healthy parts of your body, also known as an autoimmune response. These symptoms can show up even months after starting treatment. Always let your care team know if you notice new or unusual symptoms while taking your HIV medication.
Some people who take Descovy (emtricitabine / tenofovir alafenamide) have had kidney problems. To help protect your kidneys, try to avoid other medications that can also harm the kidneys, like high doses of nonsteroidal anti-inflammatory drugs (NSAIDs). Before you start Descovy (emtricitabine / tenofovir alafenamide), and during treatment, your prescriber will check your kidney health with blood tests and urine tests. Let your prescriber know right away if you experience bone or muscle pain, pain in your arms or legs, and general weakness that doesn't go away. These might be signs of kidney problems.
In rare cases, Descovy (emtricitabine / tenofovir alafenamide) can cause a serious condition called lactic acidosis, which is when too much acid builds up in your blood. It can also cause severe liver problems which can sometimes be life-threatening.
Make sure to get blood tests done while you take Descovy (emtricitabine / tenofovir alafenamide) so your prescriber can check for these harmful side effects and make sure the medication is still safe to take. Tell your care team right away if you feel very weak or tired, have trouble breathing, nausea, vomiting, stomach pain, or notice your skin or eyes turning yellow.
| Dosage | Quantity | Price as low as | Price per unit |
|---|---|---|---|
| 200mg/25mg | 30 tablets | $2,152.64 | $71.75 |
| 120mg/15mg | 30 tablets | $2,120.46 | $70.68 |
HIV treatment
Prevention of HIV (PrEP)
Contraindications are specific health conditions or situations in which a person should not take a medication due to safety concerns. If you have any of the following conditions or if any of the following apply to you, let your healthcare provider know because Descovy (emtricitabine / tenofovir alafenamide) will not be safe for you to take.